Literature DB >> 2618516

Early outcome after emergency and elective surgery for ulcerative colitis.

G Frykholm1, L Påhlman, P Enblad, M Krog, S Ejerblad.   

Abstract

The early outcome after surgical treatment of ulcerative colitis was retrospectively analyzed in 185 patients. The operation was performed on emergency indications in 25 cases, and was subacute in 53 and elective in 107. The postoperative mortality was 7% overall, 24% in the emergency group, 8% in the subacute group and 2% in the elective group. At least one early postoperative complication occurred in 71 (38%) of the 185 patients (92%, 38% and 26% in the respective groups). Infection was the predominant problem, occurring in 26% of the patients. The mortality was highest after colectomy and ileostomy, but this procedure was used in the most sick patients. Proctocolectomy was associated with the highest morbidity in all groups, whereas colectomy and ileorectal anastomosis carried no mortality and little morbidity.

Entities:  

Mesh:

Year:  1989        PMID: 2618516

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  3 in total

1.  Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.

Authors:  Joel H Rubenstein; Akbar K Waljee; Joanne M Jeter; Fernando S Velayos; Uri Ladabaum; Peter D R Higgins
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

Review 2.  Colectomy in patients with acute colitis: a systematic review.

Authors:  P H E Teeuwen; M W J Stommel; A J A Bremers; G J van der Wilt; D J de Jong; R P Bleichrodt
Journal:  J Gastrointest Surg       Date:  2009-01-09       Impact factor: 3.452

3.  Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study.

Authors:  Anders Tøttrup; Rune Erichsen; Claus Sværke; Søren Laurberg; Henrik Toft Srensen
Journal:  BMJ Open       Date:  2012-04-05       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.